Inventor · disambiguated record
Fausto Pivetti
Also filed as: PIVETTI FAUSTO
18 granted patents·10 pending applications·36 citations·filing 1998–2024
91Inventor score
Top patents by PatentIndex Score
28 records- 0191US11981639B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 0290US11352327B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2020·Granted Jun 7, 2022·2 cites·5 claims
- 0390US9434691B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2014·Granted Sep 6, 2016·6 cites·26 claims
- 0489US9890122B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2016·Granted Feb 13, 2018·3 cites·4 claims
- 0588US10759761B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2019·Granted Sep 1, 2020·2 cites·9 claims
- 0688US10323003B2Process for the preparation of a PDE4 inhibitorCHIESI FARM SPA·Filed 2017·Granted Jun 18, 2019·3 cites·11 claims
- 0785US7381402B2Stable pharmaceutical solution formulations for pressurized metered dose inhalersCHIESI FARMA SPA·Filed 2005·Granted Jun 3, 2008·9 cites·31 claims
- 0885US2024166605A1Process for the preparation of a pde4 inhibitorCHIESI FARM SPA·Filed 2024·Application pending·0 cites
- 0978US10350164B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2018·Granted Jul 16, 2019·2 cites·20 claims
- 1070US9056818B2Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acidPIVETTI FAUSTO·Filed 2010·Granted Jun 16, 2015·3 cites·6 claims
- 1165US2014135399A1Novel polymorphs and saltsCHIESI FARMA SPA·Filed 2014·Application pending·0 cites
- 1264US8076505B2Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acidFOLLEAS BENOIT·Filed 2009·Granted Dec 13, 2011·4 cites·14 claims
- 1360US2016193165A1Novel polymorphs and saltsCHIESI FARMA SPA·Filed 2016·Application pending·0 cites
- 1459US8399406B2Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)PIVETTI FAUSTO·Filed 2010·Granted Mar 19, 2013·1 cites·25 claims
- 1557US8673978B2Polymorphs and saltsPIVETTI FAUSTO·Filed 2011·Granted Mar 18, 2014·0 cites·17 claims
- 1650US2009280068A1Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochlorideCHIESI FARMA SPA·Filed 2009·Application pending·0 cites
- 1750US2009280067A1Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochlorideCHIESI FARMA SPA·Filed 2009·Application pending·0 cites
- 1849US2014364479A1Process for the preparation of glycopyrronium chlorideCHIESI FARMA SPA·Filed 2014·Application pending·0 cites
- 1948US8163922B2Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloridePIVETTI FAUSTO·Filed 2009·Granted Apr 24, 2012·0 cites·22 claims
- 2045US2007025920A1Stable Pharmaceutical Solution Formulations for Pressurized Metered Dose InhalersLEWIS DAVID·Filed 2006·Application pending·0 cites
- 2142US8877164B2Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agentLEWIS DAVID ANDREW·Filed 2006·Granted Nov 4, 2014·0 cites·15 claims
- 2241US9174937B2Crystal form of glycopyrronium chloridePIVETTI FAUSTO·Filed 2011·Granted Nov 3, 2015·0 cites·19 claims
- 2341US2007197586A18-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its PreparationCHIESI FARMA SPA·Filed 2005·Application pending·0 cites
- 2440US2011306650A1Process for the preparation of glycopyrronium chloridePIVETTI FAUSTO·Filed 2011·Application pending·0 cites
- 2536US10786450B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2018·Granted Sep 29, 2020·0 cites·16 claims
- 2636US2011044913A18-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone hemi-fumarateCHIESI FARMA SPA·Filed 2010·Application pending·0 cites
- 2733US8128909B2Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalationCAPOCCHI ANDREA·Filed 2003·Granted Mar 6, 2012·0 cites·14 claims
- 2827US6297237B1Process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activityCHIESI FARMA SPA·Filed 1998·Granted Oct 2, 2001·0 cites·35 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →